CD8A and colorectal carcinoma: This hypothesis could explain the limited efficacy of immune checkpoint inhibitors in microsatellite-stable CRC and suggests that obstructed patients might not benefit from PD-1/PD-L1 monotherapy despite having a high density of CD8+ T cells.